DYADIC INTERNATIONAL INC
DYAI · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Francisco Trust under agreement dated February 28, 1996: Form 4
Insider disclosure · Filed · Report period 22 Jul 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-K/A
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- DYAI · 26745T101 - Common Stock, $0.001 par value per share
Company details and SEC sources
CIK 0001213809 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- DYAI on Nasdaq
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- 1044 North U.S. Highway One, Suite 201, Jupiter, FL, 33477
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- CCP WORLDWIDE INC (to 05 Nov 2004)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields